Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000274963 | SCV000345683 | uncertain significance | not provided | 2016-12-27 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000764450 | SCV000895512 | uncertain significance | Achromatopsia 2 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000274963 | SCV001228428 | pathogenic | not provided | 2023-08-11 | criteria provided, single submitter | clinical testing | This sequence change replaces histidine, which is basic and polar, with arginine, which is basic and polar, at codon 345 of the CNGA3 protein (p.His345Arg). This variant is present in population databases (rs780411290, gnomAD 0.02%). This missense change has been observed in individual(s) with clinical features of CNGA3-related conditions (Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 291008). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on CNGA3 protein function. For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV000274963 | SCV002102604 | uncertain significance | not provided | 2022-03-01 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |